CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,893 | +61.1% | 31,984 | +85.2% | 0.01% | +55.6% |
| Q2 2023 | $232,096 | -91.1% | 17,269 | -89.0% | 0.01% | -91.7% |
| Q1 2023 | $2,598,451 | +76.1% | 156,722 | +97.6% | 0.11% | +38.5% |
| Q4 2022 | $1,475,519 | +142.3% | 79,329 | +67.0% | 0.08% | +225.0% |
| Q3 2022 | $609,000 | +6.1% | 47,500 | -42.0% | 0.02% | -4.0% |
| Q2 2022 | $574,000 | -33.1% | 81,901 | -20.9% | 0.02% | -32.4% |
| Q1 2022 | $858,000 | +3.5% | 103,494 | -15.4% | 0.04% | -28.8% |
| Q4 2021 | $829,000 | +278.5% | 122,400 | +222.2% | 0.05% | +147.6% |
| Q2 2021 | $219,000 | -13.8% | 37,983 | -31.1% | 0.02% | -12.5% |
| Q1 2021 | $254,000 | +62.8% | 55,100 | +5.0% | 0.02% | -22.6% |
| Q3 2020 | $156,000 | – | 52,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |